The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Infectious Agents and Disease
Volume 15 - 2024 |
doi: 10.3389/fmicb.2024.1507505
Prevalence and antibiotic resistance profile of UTI-causing uropathogenic bacteria in diabetics and non-diabetics at the Maternity and Children Hospital in Jeddah, Saudi Arabia
Provisionally accepted- 1 Department of Microbiology, Faculty of Science, Ain Sham University, Cairo, Egypt
- 2 Laboratory Department, Medical Center, Taibah University, Al-Madinah, Saudi Arabia
- 3 Department of Oncology and Medical Histology Pathology, Medical Sciences College, Taibah University, Al-Madinah, Saudi Arabia
- 4 Maternity and Children Hospital, Microbiology Laboratory, Jeddah, Saudi Arabia
- 5 Department of Family and Community Medicine, College of Medicine, Taibah University, Madinah, Al Madinah, Saudi Arabia
One of the most prevalent and recurrent infectious diseases that can range from moderate to fatal is urinary tract infection (UTI). Broad-spectrum antibiotics are the only management strategy for UTIs in ambulators and hospital stays. Due to the ongoing emergence of antibiotic resistance among uropathogens, there is a need for proper selection of antibiotics for empirical therapy against UTIs.This study aimed to compare the etiological profiles and antibiotic susceptibility patterns between diabetic and non-diabetic UTI female patients from the Maternity and Children Hospital in Jeddah, Saudi Arabia. Urine samples from different age categories of female UTI patients were collected from January 2021 to June 2023. The positive urine cultures with a single pathogen were selected and all bacterial isolates were identified by MALDI-TOF/MS system. Antibiotic susceptibility testing was done using VITEK-2. Our study included 2245 female patients, of which 1825 (81%) were nondiabetic and 420 (19%) were diabetic. The results showed a significant relationship (p=0.00063) between the average age and the number of diabetic UTI patients. Gram-negative bacilli were more dominant (84.7%, n=1903) than gram-positive cocci (15.3%, n=342). Escherichia coli (40.8%) was the most prevalent pathogen identified with a significant (p<0.0001) increase in non-diabetic (45.26%) than diabetic UTI patients (21.43%). Proteus mirabilis (10.2%) and Pseudomonas aeruginosa (8.7%) followed E. coli in pathogen distribution. Among gram-positive species, Enterococcus faecalis, Staphylococcus aureus, and Staphylococcus saprophyticus were found in all age groups of diabetic and non-diabetic UTI patients. The findings showed that the most resistant bacteria from patients with nondiabetic UTIs were found to be resistant to amoxicillin (37.7%) and ampicillin (40%), while the most resistant bacteria from patients with diabetes were found to be resistant to tetracycline (43.3%) and cephalothin (43.5%). In patients with UTIs, ciprofloxacin was found to be the most effective antibiotic against all bacterial species. According to the results, we concluded that the UTI etiological profiles varied among different ages. Ciprofloxacin is a safe medication with optimal sensitivity that can be used to treat both gram-positive and gram-negative bacteria.
Keywords: Urinary tract infection, Female patients, etiological profiles, antibiotic resistance, age categories
Received: 07 Oct 2024; Accepted: 06 Nov 2024.
Copyright: © 2024 Farag, Albulushi, Eskembaji, Habash, Malki, Albadrani and Hanafy. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ahmed M. Hanafy, Department of Microbiology, Faculty of Science, Ain Sham University, Cairo, Egypt
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.